Organisational health consulting firm, Q5, has welcomed Amanda Lewis as its new chief financial officer. This strategic addition to the leadership team marks a significant step forward as Q5 continues its global growth journey.
Amanda brings over two decades of experience as a transformative finance leader, and was most recently the chief financial officer at The Chemistry Group. She helped the business through an M&A process, attracting top-tier talent to help move the company into its next phase of growth. She also played a key role in fostering a culture of data transparency, facilitating strategic insights, improving operational efficiency, and aligning cost structures with financial targets.
Now, as chief financial officer at Q5, Amanda is responsible for shaping and executing the company’s strategy of doubling in size by 2030 in a sustainable way. Q5 has doubled in size between 2020 and 2025, and has grown from a footprint of four offices to nine. Amanda will work closely with the leadership team to achieve this goal, driving growth in the Middle East, North America, and Australia.
Reflecting on her new role, Amanda said: “I am thrilled to join the Q5 team and be part of an award-winning firm that is helping to build better businesses across the world. I’m passionate about driving client and partner success, while also coaching and mentoring a team to create a high-performing environment. I look forward to the growth we can achieve together.”
Olly Purnell, managing partner at Q5, added: “It’s wonderful to have Amanda on board. She inherits an excellent Finance team, but will bring experience and commercial finance nous and leadership that will hopefully enable us to be more global in the way we approach things.”
